Sort
30,917 grants matching “tumor microenvironment”
PET Imaging of Hypoxia with EF5
$368,776University Of Pennsylvania · R01 · FY2005 · CA
Exploiting dual-TCR for rescue of CD8 T cell tolerance in adoptive immunotherapy
$368,750Ryan M Teague · Saint Louis University · R01 · FY2010 · AI
Surgical Oncologists as Scientists (SOAS) Training Program
$368,648Jason Keith Sicklick · University Of California, San Diego · T32 · FY2024 · CA
Regulation of Pathogenic Plasma Cells in Human SLE
$368,606Ignacio E. Sanz · Emory University · P01 · FY2016 · AI
Quinolinate-induced immune suppression in glioblastoma
$368,600Prakash Chinnaiyan · William Beaumont Hospital Research Inst · R01 · FY2024 · NS
Normalizing PDAC stroma with PCBP2 siRNA nanoparticles to improve the antitumor activity of chemotherapy and immunotherapy
$368,579Kun Cheng · University Of Missouri Kansas City · R01 · FY2023 · CA
Ecology and Evolution of Breast Carcinogenesis
$368,556Mehdi Damaghi · State University New York Stony Brook · U01 · FY2025 · CA
P38 MAPK is a molecular switch that controls the acquired resistance in adoptive cell therapy
$368,487Yong Lu · Methodist Hospital Research Institute · R37 · FY2022 · CA
Use of Organotypic and Mammary Gland Models to Investigate the Outcomes of Clonal
$368,455Joan Siefert Brugge · Whitehead Institute For Biomedical Res · P01 · FY2011 · CA
Role of Intestinal Bacteria in Human Norovirus Infection
$368,455Stephanie Karst · University Of Florida · R01 · FY2019 · AI
Bioinformatics Tools for Genomic Analysis of Tumor and Stromal Pathways in Cancer
$368,454Giovanni Parmigiani · Dana-Farber Cancer Inst · R01 · FY2013 · CA
Project 3: Modulation of the head and neck tumor immune microenvironment by targeting the TAM family of receptors
$368,400Deric L Wheeler · University Of Wisconsin-Madison · P50 · FY2024 · CA
Quantitative FDG-PET for Hepatomacellular Carcinoma
$368,389Case Western Reserve University · R01 · FY2003 · CA
Chemokine Signals in the Premetastatic Niche Inhibit Metastasis
$368,383Ann Richmond · Vanderbilt University · R01 · FY2015 · CA
Potentiating Checkpoint Blockade by Cross-Priming Tumor-Reactive T cells with In Situ Vaccination
$368,346Joshua D Brody · Icahn School Of Medicine At Mount Sinai · R37 · FY2024 · CA
UCSC-Buck Specialized Genomic Data Analysis Center for the Genomic Data Analysis Network
$368,332Joshua Michael Stuart · University Of California Santa Cruz · U24 · FY2019 · CA
Local Regulation of Angiogenesis by Microenvironment
$368,325Christopher S Chen · Boston University (Charles River Campus) · R01 · FY2015 · EB
The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells
$368,288Steven Mark Albelda · University Of Pennsylvania · R01 · FY2021 · CA
Microfluidic platform for tumor cell invasion
$368,288Mingming Wu · Cornell University · R01 · FY2018 · CA
Regulation of antigen presenting cells in the tumor microenvironment by retinoic acid
$368,288Malay Haldar · University Of Pennsylvania · R37 · FY2020 · CA
Macrophage-based Therapy and Immune Checkpoint Blockade for Glioblastoma
$368,288Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · CA
Targeting macrophages for immunotherapy in pancreatic cancer
$368,288Gregory L Beatty · University Of Pennsylvania · R01 · FY2018 · CA
Microfluidic platform for tumor cell invasion
$368,288Mingming Wu · Cornell University · R01 · FY2020 · CA
The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells
$368,288Edmund K. Moon · University Of Pennsylvania · R01 · FY2020 · CA
Role of Perivascular Mesenchymal Stem Cells (pMSCs) in the Bone Marrow Niche and the Extracellular Matrix in the Control of Skeletal Metastasis
$368,288Arnold I. Caplan · Case Western Reserve University · R01 · FY2020 · CA